SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-033434
Filing Date
2017-02-07
Accepted
2017-02-07 17:21:02
Documents
3
Period of Report
2017-02-01
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d337650d8k.htm 8-K 19329
2 EX-99.1 d337650dex991.htm EX-99.1 6584
3 GRAPHIC g337650peiries.jpg GRAPHIC 12753
  Complete submission text file 0001193125-17-033434.txt   45027
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 17580103
SIC: 8731 Services-Commercial Physical & Biological Research